Cargando…
Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis
Resistance to isoniazid (INH) and rifampicin (RIF) first-line drugs in Mycobacterium tuberculosis (Mtb), together called multi-drug resistance, threatens tuberculosis control. Resistance mutations in katG (for INH) and rpoB (RIF) genes often come with fitness costs. To overcome these costs, Mtb comp...
Autores principales: | Napier, Gary, Campino, Susana, Phelan, Jody E., Clark, Taane G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837068/ https://www.ncbi.nlm.nih.gov/pubmed/36635309 http://dx.doi.org/10.1038/s41598-023-27516-4 |
Ejemplares similares
-
A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis
por: Deelder, Wouter, et al.
Publicado: (2022) -
Mixed infections in genotypic drug-resistant Mycobacterium tuberculosis
por: Wang, Linfeng, et al.
Publicado: (2023) -
Portable sequencing of Mycobacterium tuberculosis for clinical and epidemiological applications
por: Gómez-González, Paula J, et al.
Publicado: (2022) -
Robust barcoding and identification of Mycobacterium tuberculosis lineages for epidemiological and clinical studies
por: Napier, Gary, et al.
Publicado: (2020) -
Whole genome sequencing reveals large deletions and other loss of function mutations in Mycobacterium tuberculosis drug resistance genes
por: Gomes, Laura C., et al.
Publicado: (2021)